Understanding how specific viral RNA affects infection and disease caused by alphaviruses.
Comprehensive Definition of the Critical Role(s) of the Alphaviral Noncapped Genomic RNAs to Infection and Pathogenesis
This study is looking into how certain viral RNAs from alphaviruses, which can cause serious illnesses, affect how these viruses make us sick, with the goal of helping to create better treatments and vaccines for diseases like Sindbis and Ross River virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10828381 on NIH RePORTER |
What this research studies
This research investigates the role of noncapped genomic RNAs produced by alphaviruses, which are known to cause significant outbreaks of disease. The study aims to uncover the mechanisms by which these viral RNAs influence infection and disease progression. By conducting detailed molecular analyses, the researchers will explore how these RNAs contribute to the overall pathogenesis of viruses like Sindbis and Ross River virus. This work is crucial for developing effective antiviral therapies and vaccines, as current options are lacking.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been infected with alphaviruses or are at risk of such infections.
Not a fit: Patients who are not affected by alphavirus infections or do not have a history of related diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral treatments and vaccines for alphavirus infections.
How similar studies have performed: Previous research has shown promise in understanding viral mechanisms, but this specific focus on noncapped genomic RNAs is relatively novel.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Sokoloski, Kevin Joseph — University of Louisville
- Study coordinator: Sokoloski, Kevin Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.